Biogen Inc. Business Finance Contracts & Agreements

45 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Credit Agreement, dated as of August 12, 2024, among Biogen Inc., Bank of America, N.A., as administrative agent, swing line lender and the L/C issuer, and the other lenders party...
Credit Agreements
Biogen Inc.
Biotechnology
DE
2024
Form of restricted stock unit award agreement for non-employee Director's under the Biogen Inc. 2024 Omnibus Equity Plan
Stock Agreements
Biogen Inc.
Biotechnology
DE
2024
Form of restricted stock unit award agreement under the Biogen Inc. 2024 Omnibus Equity Plan
Stock Agreements
Biogen Inc.
Biotechnology
DE
2024
Credit Agreement, dated as of August 28, 2023 among Biogen Inc., JPMorgan Chase Bank N.A., as administrative agent and the other lenders party thereto
Credit Agreements
Biogen Inc.
Biotechnology
DE
2023
Registration Rights Agreement, dated February 16, 2021, between Biogen Inc. and Deutsche Bank Securities Inc. and Citigroup Global Markets, Inc. with respect to the 3.250% Senior...
Note Agreements
Biogen Inc.
Biotechnology
NY
2021
Form of 3.250% Senior Notes due 2051, in the form of a Global Note bearing a Regulation S legend
Note Agreements
Biogen Inc.
Biotechnology
NY
2021
Form of 3.250% Senior Notes due 2051, in the form of a Global Note bearing a private placement legend
Note Agreements
Biogen Inc.
Biotechnology
NY
2021
Third Supplemental Indenture, dated February 16, 2021, between Biogen Inc. and U.S. Bank National Association
Indenture Agreements
Biogen Inc.
Biotechnology
DE
2021
Second Supplemental Indenture, dated April 30, 2020, between Biogen Inc. and U.S. Bank National Association, including the forms of Global Notes attached as Exhibit A and Exhibit...
Indenture Agreements
Biogen Inc.
Biotechnology
NY
2021
Second Supplemental Indenture, dated April 30, 2020, between the Company and U.S. Bank National Association, including the forms of Global Notes attached as Exhibit A and Exhibit...
Indenture Agreements
Biogen Inc.
Biotechnology
DE
2020
Underwriting Agreement, dated April 27, 2020, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the...
Underwriting Agreements
Biogen Inc.
Biotechnology
2020
Credit Agreement, dated as of January 28, 2020, among Biogen Inc., Bank of America, N.A., as administrative agent, swing line lender and the L/C issuer, and the other lenders...
Credit Agreements
Biogen Inc.
Biotechnology
DE
2020
Form of market stock unit award agreement under the Biogen Inc. 2017 Omnibus Equity Plan (for grants commencing in July 2019)
Stock Agreements
Biogen Inc.
Biotechnology
DE
2019
Form of restricted stock unit award agreement (2018 one-time transition grant) under the Biogen Inc. 2017 Omnibus Equity Plan
Stock Agreements
Biogen Inc.
Biotechnology
DE
2018
MARKET STOCK UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN INC. 2017 OMNIBUS EQUITY PLAN
Stock Agreements
Biogen Inc.
Biotechnology
DE
2017
RESTRICTED STOCK UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN INC. 2017 OMNIBUS EQUITY PLAN
Stock Agreements
Biogen Inc.
Biotechnology
DE
2017
BIOGEN INC., as Issuer and U.S. BankNational Association, as Trustee First Supplemental Indenture Dated as of September 15, 2015 TABLE OF CONTENTS
Indenture Agreements
Biogen Inc.
Biotechnology
DE
2015
BIOGEN INC. and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Debt Securities Dated as of September 15, 2015 CROSS-REFERENCE TABLE
Indenture Agreements
Biogen Inc.
Biotechnology
DE
2015
Biogen Inc. 2.900%Senior Notes due 2020 3.625% Senior Notes due 2022 4.050% Senior Notes due 2025 5.200% Senior Notes due 2045 Underwriting Agreement
Underwriting Agreements
Biogen Inc.
Biotechnology
2015
CREDIT AGREEMENT Dated as of August 28, 2015 among BIOGEN INC. as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and an L/C Issuer, GOLDMAN SACHS...
Credit Agreements
Biogen Inc.
Biotechnology
DE
2015
MARKET STOCK UNIT AWARD AGREEMENT GRANTED UNDER BIOGEN IDEC INC. 2008 OMNIBUS EQUITY PLAN
Stock Agreements
Biogen Inc.
Biotechnology
DE
2014
Exhibit A REAFFIRMATION OF RELEASE OF CLAIMS
Release Agreements
Biogen Inc.
Biotechnology
2014
CREDIT AGREEMENT Dated as of March 14, 2013 among BIOGEN IDEC INC. as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, CREDIT SUISSE...
Credit Agreements
Biogen Inc.
Biotechnology
DE
2013
ASSET PURCHASE AGREEMENT by and among ELAN PHARMA INTERNATIONAL LIMITED, ELAN PHARMACEUTICALS, INC. and BIOGEN IDEC INTERNATIONAL HOLDING LTD. Dated as of February 5, 2013
Purchase Agreements
Biogen Inc.
Biotechnology
NY
2013
EX-10.2 Form of market stock unit award agreement under the 2008 Omnibus Equity Plan
Stock Agreements
Biogen Inc.
Biotechnology
DE
2010
Ex-10.1 Amendment No.1 to Credit Agreement
Credit Agreements
Biogen Inc.
Biotechnology
NY
2009
Ex-10.45 Amendment to Biogen, Inc. 1985 Non-Qualified Stock Option Plan dated October 13, 2008
Stock Agreements
Biogen Inc.
Biotechnology
2009
Ex-4.4 Amendment No. 2 to Amended and Restated Rights Agreement between Biogen Idec and Mellon Investor Services LLC dated as of January 22, 2009
Investor Rights Agreements
Biogen Inc.
Biotechnology
NJ
2009
Ex-10.2 Form of nonqualified stock option award agreement
Stock Agreements
Biogen Inc.
Biotechnology
DE
2008
Ex-10.1 Form of resticted stock unit award agreement
Stock Agreements
Biogen Inc.
Biotechnology
DE
2008
EX-10.5 Amendment to IDEC Pharmaceuticals Corporation 1993 Non-Employee Directors Stock Option Plan dated April 18, 2008
Stock Agreements
Biogen Inc.
Biotechnology
2008
EX-10.4 Amendment to IDEC Pharmaceuticals Corporation 1988 Stock Option Plan dated April 18, 2008
Stock Agreements
Biogen Inc.
Biotechnology
2008
EX-10.3 Amendment to Biogen, Inc. 1987 Scientific Board Stock Option Plan dated April 18, 2008
Stock Agreements
Biogen Inc.
Biotechnology
2008
EX-10.2 Amendment to Biogen, Inc. 1985 Non-Qualified Stock Option Plan dated April 18, 2008
Stock Agreements
Biogen Inc.
Biotechnology
2008
TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS 1 SECTION 1.1. Certain Terms Defined in the Indenture 1 SECTION 1.2. Definitions 2 ARTICLE II. FORM AND TERMS OF THE NOTES 5 SECTION...
Indenture Agreements
Biogen Inc.
Biotechnology
NY
2008
Ex-10.22 1985 Non-Qualified Stock Option Plan
Stock Agreements
Biogen Inc.
Biotechnology
MA
2008
Ex-10.1 Form of Grant Notice (Restricted Stock Units)
Stock Agreements
Biogen Inc.
Biotechnology
2005
Ex-10.1 Purchase and Sale Agreement and Joint Escrow Instructions
Escrow Agreements
Biogen Inc.
Biotechnology
CA
2005
EX-10.1 AMENDMENT TO 1998 STOCK PLAN
Stock Agreements
Biogen Inc.
Biotechnology
2004
EX-4.2 SPECIMEN COMMON STOCK CERTIFICATE
Stock Agreements
Biogen Inc.
Biotechnology
2004